Comprehensive magnetic resonance imaging of the small and large bowel using intraluminal dual contrast technique with iron oxide solution and water in magnetic resonance enteroclysis

Investigative Radiology

Volumn 40, Issue 9, 2005, Pages 621-629

  Herrmann, Karin A ^a   Zech, Christoph J ^a   Michaely, Henrik J ^a   Seiderer, Julia ^a   Ochsenkuehn, Thomas ^a   Reiser, Maximilian F ^a   Schoenberg, Stefan O ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Abdomen; Contrast media; Crohn disease; Gastrointestinal tract; MR; Technique

Indexed keywords

CONTRAST MEDIUM; ENEMA; FERUMOXSIL; GADOLINIUM PENTETATE; IRON OXIDE; KLEANPREP; MACROGOL; SCOPOLAMINE BUTYL BROMIDE; WATER;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; ILEUM; INTESTINE DISTENSION; LARGE INTESTINE; LARGE INTESTINE DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PRIORITY JOURNAL; RADIODIAGNOSIS; SMALL INTESTINE; SMALL INTESTINE DISEASE;

EID: 23944523353     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rli.0000175037.15022.85     Document Type: Article

References (34)

1. Maglinte DD, Siegelman ES, Kelvin FM. MR enteroclysis: the future of small-bowel imaging? Radiology. 2000;215:639-641.
2. Umschaden HW, Szolar D, Gasser J, et al. Small-bowel disease: comparison of MR enteroclysis images with conventional enteroclysis and surgical findings. Radiology. 2000;215:717-725.
3. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, et al. MR enteroclysis: technical considerations and clinical applications. Eur Radiol. 2002;12:2651-2658.
4. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, et al. MR imaging of the small bowel with a true-FISP sequence after enteroclysis with water solution. Invest Radiol. 2000;35:707-711.
5. Prassopoulos P, Papanikolaou N, Grammatikakis J, et al. MR enteroclysis imaging of Crohn disease. Radiographics. 2001;21:S161-172.
6. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, et al. MR enteroclysis protocol optimization: comparison between 3D FLASH with fat saturation after intravenous gadolinium injection and true FISP sequences. Eur Radiol. 2001;11:908-913.
7. Maccioni F, Viscido A, Broglia L, et al. Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging. 2000;25:219-228.
8. Wills JS, Lobis IF, Denstman FJ. Crohn disease: state of the art. Radiology. 1997;202:597-610.
9. Pels Rijcken TH, Davis MA, Ros PR. Intraluminal contrast agents for MR imaging of the abdomen and pelvis. J Magn Reson Imaging. 1994; 4:291-300.
10. Herrmann KA, Lienemann AH, Holzknecht NG, et al. Dynamic magnetic resonance (MR) enteroclysis of the small bowel with MR-fluoroscopy. Radiology. 2002;225(suppl):394.
11. Zech CJ, Herrmann KA, Huber A, et al. High-resolution MR-imaging of the liver with T2-weighted sequences using integrated parallel imaging: comparison of prospective motion correction and respiratory triggering. J Magn Reson Imaging. 2004;20:443-450.
12. Minowa O, Ozaki Y, Kyogoku S, et al. MR imaging of the small bowel using water as a contrast agent in a preliminary study with healthy volunteers. AJR Am J Roentgenol. 1999;173:581-582.
13. Prassopoulos P, Papanikolaou N, Maris T, et al. Development of contrast-enhanced virtual MR cholangioscopy: a feasibility study. Eur Radiol. 2002;12:1438-1441.
14. Low RN, Francis IR. MR imaging of the gastrointestinal tract with iv, gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT. AJR Am J Roentgenol. 1997;169:1051-1059.
15. Laghi A, Paolantonio P, Catalane C, et al. MR imaging of the small bowel using polyethylene glycol solution as an oral contrast agent in adults and children with celiac disease: preliminary observations. AJR Am J Roentgenol. 2003;180:191-194.
16. Papanikolaou N, Prassopoulos P, Grammatikakis J, et al. Optimization of a contrast medium suitable for conventional enteroclysis, MR enteroclysis, and virtual MR enteroscopy. Abdom Imaging. 2002;27:517-522.
17. Umschaden HW, Gasser J. MR enteroclysis. Radiol Clin North Am. 2003;41:231-248.
18. Faber SC, Stehling MK, Holzknecht N, et al. Pathologic conditions in the small bowel: findings at fat-suppressed gadolinium-enhanced MR imaging with an optimized suspension of oral magnetic particles. Radiology. 1997;205:278-282.
19. Rieber A, Aschoff A, Nussle K, et al. MR1 in the diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis. Eur Radiol. 2000;10:1377-1382.
20. Holzknecht N, Helmberger T, Herrmann K, et al. [MRI in Crohn's disease after transduodenal contrast administration using negative oral MR1 contrast media]. Radiologe. 2003;43:43-50.
21. Maccioni F, Viscido A, Marini M, et al. MR1 evaluation of Crohn's disease of the small and large bowel with the use of negative superparamagnetic oral contrast agents. Abdom Imaging. 2002;27:384-393.
22. Hahn PF, Stark DD, Lewis JM, et al. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology. 1990;175:695-700.
23. Holzknecht N, Helmberger T, von Ritter C, et al. [MRI of the small intestine with rapid MR1 sequences in Crohn disease after enteroclysis with oral iron particles]. Radiologe. 1998;38:29-36.
24. Ajaj W, Debatin JF, Lauenstein T. Dark-lumen MR colonography. Abdom Imaging. 2004;29:429-433.
25. Papanikolaou N, Grammatikakis J, Maris T, et al. MR colonography with fecal tagging: comparison between 2D turbo FLASH and 3D FLASH sequences. Eur Radiol. 2003;13:448-452.
26. Debatin JF, Lauenstein TC. Virtual magnetic resonance colonography. Gut. 2003;52(suppl 4):iv17-22.
27. Lauenstein TC, Ajaj W, Kuehle CA, et al. Magnetic resonance colonography: comparison of contrast-enhanced three-dimensional VIBE with two-dimensional FISP sequences: preliminary experience. Invest Radiol. 2005;40:89-96.
28. Scheibl K, Schreyer AG, Kullmann F, et al. magnetic resonance imaging gastrography: evaluation of the dark lumen technique compared with conventional gastroscopy in patients with malignant gastric disease. Invent Radiol. 2005;40:164-172.
29. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, et al. Assessment of Crohn's disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur Radiol. 2004;14:1017-1024.
30. Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther. 2002;16:51-60.
31. Shoenut JP, Semelka RC, Magro CM, et al. Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease. J Clin Gastroenterol. 1994;19:31-35.
32. Darbari A, Sena L, Argani P, et al. Gadolinium-enhanced magnetic resonance imaging: a useful radiological tool in diagnosing pediatric IBD. Inflamm Bowel Dis. 2004;10:67-72.
33. Madsen SM, Thomsen HS, Munkholm P, et al. Inflammatory bowel disease evaluated by low-field magnetic resonance imaging. Comparison with endoscopy, 99mTc-HMPAO leucocyte sctntigraphy, conventional radiography and surgery. Scand J Gastroenterol. 2002;37:307-316.
34. Narin B, Ajaj W, Gohde S, et al. Combined small and large bowel MR imaging in patients with Crohn's disease: a feasibility study. Eur Radiol. 2004;14:1535-1542.